<DOC>
	<DOC>NCT02398188</DOC>
	<brief_summary>This is a multi-center, randomized, double-blinded, placebo-controlled study evaluating the safety and efficacy of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese subjects.</brief_summary>
	<brief_title>Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)</brief_title>
	<detailed_description />
	<criteria>Healthy male or nonpregnant female subjects Capable of providing written consent. BMI &lt; 30 kg/m2 Stable diet and exercise routine Central abdominal bulging that is evaluated by the clinician at least slight bulge, not flat Have had any treatment of the fat around your abdomen, including surgical procedures (tummy tuck, liposuction), injections for fat loss or treatments with devices to reduce fat in your abdomen. Plan on starting a weight loss or exercise program during the study. Known hypersensitivity to study drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>